We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

157 hedge funds and large institutions have $817M invested in Intersect ENT, Inc in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $696K

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

12% more funds holding

Funds holding: 140157 (+17)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

3% more capital invested

Capital invested by funds: $792M → $817M (+$25.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
157
Holders Change
+17
Holders Change %
+12.14%
% of All Funds
3.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
54
Reduced
52
Closed
12
Calls
$5.8M
Puts
$696K
Net Calls
+$5.1M
Net Calls Change
+$322K
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$1.07M -$382K -12,751 -28%
CS
77
Candriam SCA
Luxembourg
$1.07M +$990K +33,000 New
New York State Common Retirement Fund
78
New York State Common Retirement Fund
New York
$1.02M +$88.5K +2,951 +10%
EI
79
EAM Investors
California
$1.01M -$3.99M -132,983 -81%
N
80
Nuveen
North Carolina
$994K +$920K +30,690 New
BA
81
Boston Advisors
Massachusetts
$942K +$17.4K +580 +2%
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$935K +$355K +11,852 +70%
Squarepoint
83
Squarepoint
New York
$871K +$276K +9,204 +52%
SO
84
STRS Ohio
Ohio
$858K
Barclays
85
Barclays
United Kingdom
$851K +$88.2K +2,942 +13%
RhumbLine Advisers
86
RhumbLine Advisers
Massachusetts
$809K -$143K -4,763 -16%
CS
87
Credit Suisse
Switzerland
$761K -$140K -4,652 -17%
California Public Employees Retirement System
88
California Public Employees Retirement System
California
$746K +$36K +1,200 +5%
MC
89
Menta Capital
California
$740K +$570 +19 +0.1%
Tudor Investment Corp
90
Tudor Investment Corp
Connecticut
$715K +$199K +6,640 +43%
HLA
91
Hamilton Lane Advisors
Pennsylvania
$699K -$300K -10,000 -32%
Manulife (Manufacturers Life Insurance)
92
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$659K +$13.1K +438 +2%
State of Wisconsin Investment Board
93
State of Wisconsin Investment Board
Wisconsin
$616K
AIG
94
American International Group
New York
$580K +$14.9K +497 +3%
HCM
95
Highbridge Capital Management
New York
$534K +$494K +16,481 New
Principal Financial Group
96
Principal Financial Group
Iowa
$487K +$451K +15,040 New
Capital Fund Management (CFM)
97
Capital Fund Management (CFM)
France
$483K +$447K +14,900 New
Ohio Public Employees Retirement System (OPERS)
98
Ohio Public Employees Retirement System (OPERS)
Ohio
$482K +$446K +14,869 New
DIA
99
Denver Investment Advisors
Colorado
$457K -$15.9K -531 -4%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$456K +$4.2K +140 +1%

XENT Hedge Fund Activity: Q4 2017 in Review

157 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2017, worth a combined $817M — up 3.2% from $792M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XENT positions and 12 closed out — a net gain of 17 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $33.6M.

  • 157 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2017, up from 140 in Q3 2017.
  • Funds reported $817M of Intersect ENT, Inc stock for Q4 2017, up 3.2% quarter-over-quarter.
  • 29 funds opened new Intersect ENT, Inc positions in Q4 2017 and 12 closed out, a net change of +17 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2017 was Point72 Asset Management, an estimated $15.3M added.
  • The largest Intersect ENT, Inc seller in Q4 2017 was Fidelity Investments, an estimated $33.6M sold.

Based on aggregated 13F filings for Q4 2017.